Value202020212022202320242025TTMCash from investing activities269 M207.7 M78.54 M207.68 M157.52 M102.61 M102.61 MCash from financing activities71.71 M6.18 M794 K20.03 M2.02 B101.04 M101.04 MFree cash flow-62.78 M568.48 M892.11 M481.49 M321.44 M1.39 B1.41 B
Incyte Corporation
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity.